According to Egetis Therapeutics AB's latest financial reports the company's current revenue (TTM ) is A$9.61 Million. In 2025 the company made a revenue of A$9.84 Million an increase over the revenue in the year 2024 that were of A$7 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.